Industry Policy Committee

Purpose: 

To promote initiatives (outside regulatory and reimbursement) which impact on industry development and sustainability and healthcare policy. 

Objectives: 

  1. Develop policy positions and engage with stakeholders on the following:  
  • Digital healthcare agenda including cybersecurity, the electronic patient record, mobile healthcare and registries.
  • Supply chain issues, including traceability of medical devices, and regularly engaged with GS1 Australia. 
  • MTP Connect initiatives, R&D, clinical trials and commercialisation. 
  • Industry input into NSW Knowledge Hun projects to support the MedTech sector. 
  • Industry input into export initiatives and issues. 
  1. Monitor the implementation of the $30 million grant for SMEs under the MTAA‐Government Agreement. 

 

MTAA Secretary: Determined by Paul Dale, Director ‐ Policy 

Member Name

Company 

Daniel Kildea (Chair) 

Johnson & Johnson Medical Pty Ltd

Damon Mogridge

Smith & Nephew Pty Ltd

Geoff Feakes

Tunstall Healthcare

George Sidis

IDE Group

Jane Crowe

Roche Diabetes Care Australia Pty Limited

Kirk Kikirekov

Prospitalia hTrak Pty Ltd

Leanne Elich

Varian Medical Systems Australasia Pty Ltd

Leonardo Cevallos

Cook Medical

Matt Malone

Stryker Australia Pty Ltd

Michael Reynolds

Biotronik Australia Pty Ltd

Paul Davies

Abbott Medical Australia Pty Ltd

Ross Lane

Cook Medical

Simon Williamson

Boston Scientific Pty Ltd

 

Meeting dates for 2020: 

  • Thursday 30th January (10am – 1pm)
  • Thursday 12th March (10am – 1pm)
  • Thursday 21st May (10am – 1pm)
  • Thursday 9th July (10am – 1pm)
  • Thursday 24th September (10am – 1pm)
  • Thursday 5th November (10am – 1pm)